Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$51,333,971
+$14,832,697 QoQ
Shares Held
2,858,239
+8.8% QoQ
Ownership
2.57%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 207 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. AMLX ranks #12 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,199,799 $229,937,554
2 VTRS
Viatris Inc
 13,564,872 $215,410,166
3 TEVA
Teva Pharmaceutical Industries Ltd
 6,129,240 $207,658,650
4 HIMS
Hims & Hers Health, Inc.
 5,173,865 $179,377,897
5 NBIX
Neurocrine Biosciences Inc
 631,892 $106,499,075
6 ALKS
Alkermes plc.
 2,023,984 $106,056,760
7 LNTH
Lantheus Holdings, Inc.
 814,096 $90,315,809
8 UTHR
UNITED THERAPEUTICS Corp
 165,979 $89,932,399

All Filings in AMLX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,333,971 2,858,239
2026-03-31 $36,501,274 2,625,991
2025-12-31 $31,567,709 2,613,221
2025-09-30 $27,324,500 2,010,633
2025-06-30 $8,320,063 1,297,982
2025-03-31 $7,090,479 2,002,961
2024-12-31 $7,030,405 1,859,896
2024-09-30 $5,228,914 1,613,863
2024-06-30 $4,959,797 2,610,420
2024-03-31 $8,358,646 2,943,186
2023-12-31 $18,500,992 1,256,861
2023-09-30 $21,736,312 1,187,128
2023-06-30 $29,129,809 1,350,478
2023-03-31 $40,083,484 1,366,172
2022-12-31 $38,290,175 1,036,270
2022-09-30 $10,680,081 379,399